Medical Director at Enterprise
High Openness and Extraversion to lead medical-scientific strategy, represent the company before agencies, and build clinical positioning.
In enterprise pharma, multi-market regulatory complexity is the norm
10-15 year development cycles require genuine long-term vision
Pharmacovigilance and patient safety are non-delegable responsibilities
Ideal OCEAN+ Profile
At enterprise companies (201-1000 employees), strategic scientific vision to design the evidence plan, lead advisory boards, and anticipate the medical landscape that will impact the portfolio
At enterprise companies (201-1000 employees), rigor in validating shared medical information, compliance with reporting obligations, and quality of the evidence strategy
At enterprise companies (201-1000 employees), executive presence in the C-suite, leadership of medical teams, and representation of the company before KOLs, agencies, and academia
At enterprise companies (201-1000 employees), cross-functional influence over commercial, regulatory, and access teams to align medical strategy with business needs
At enterprise companies (201-1000 employees), handling safety crises, public scientific controversies, and business performance pressure that demand difficult medical-ethical decisions
At enterprise companies (201-1000 employees), the Medical Director alternates between medical process governance and scientific exploration; needs comfort with regulatory frameworks without structure preventing adjustments to the evidence plan when the clinical landscape shifts
Strengths and Red Flags
Strengths
- Design of clinical evidence strategy that positions the portfolio in treatment guidelines
- Scientific representation of the company before KOLs, agencies, and public health bodies
- Managing product portfolios across multiple development and commercialization phases
- Robust regulatory compliance with FDA, EMA, and local health authorities
Red Flags
- Subordinating scientific objectivity to commercial business pressures
- Disconnection from the real clinical environment, generating medical strategies that physicians do not adopt
- Paralysis in the face of complex multi-product, multi-phase portfolios
- Internal bureaucracy that delays go/no-go pipeline decisions
Interview Questions
Describe the most complex evidence strategy you designed. How did you balance scientific needs with the business's timelines and resources?
Evaluates: Strategic Openness and ability to balance science with business
The commercial team wants to position a subgroup finding that is statistically significant but clinically questionable. What position do you take and how do you communicate it internally?
Evaluates: Conscientiousness and medical-scientific integrity under commercial pressure
How did you manage a multi-product portfolio across different development phases?
Evaluates: Systemic vision and prioritization capacity at scale
How did you coordinate a multi-market regulatory registration process?
Evaluates: Conscientiousness and coordination in highly complex environments
More about Medical Director
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Medical Director — base profile with no company context
View profile → Startup (1-50 employees)In pharma startups, time to regulatory approval defines survival
View profile → SMB (51-200 employees)In SMB pharma, quality and compliance are the license to operate
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Medical Director at Enterprise (201-1000 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card